Farshad Guirakhoo Joins Vaxess Technologies As Chief Technology Officer

Former Hookipa Biotech CSO and Sanofi/Acambis veteran to lead development of silk-based vaccine stabilization technology June 30, 2014 Vaxess Technologies, Inc., an innovative life sciences company developing a novel vaccine stabilization technology, announced today the addition of Farshad Guirakhoo, PhD, to its leadership team as Chief Technology Officer. Vaxess’s proprietary platform harnesses the unique properties of fibroin, a protein derived …